Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Updated on: September 27,2024

Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Updated on:September 27,2024

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

September 20, 2023Ashling WahnerEarly lung-specific response to atezolizumab plus bevacizumab was associated with longer overall survival in patients with hepatocellular carcinoma with pulmonary metas

Updated on: October 10,2023

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

September 20, 2023Ashling WahnerEarly lung-specific response to atezolizumab plus bevacizumab was associated with longer overall survival in patients with hepatocellular carcinoma with pulmonary metas

Updated on:October 10,2023

Comparing cancer costs is challenging, despite new price transparency rules

byUNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Trevor Royce, MD, MS, MPH, is author of a study that found a federal rule that requires hospitals to publicly list standard charg

Updated on: December 20,2023

Comparing cancer costs is challenging, despite new price transparency rules

byUNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Trevor Royce, MD, MS, MPH, is author of a study that found a federal rule that requires hospitals to publicly list standard charg

Updated on:December 20,2023

AstraZeneca to Discontinue Moxetumomab Pasudotox in US for Hairy Cell Leukemia

January 13, 2023Chris RyanMoxetumomab pasudotox-tdfk will be permanently discontinued in the United States market for the treatment of relapsed/refractory hairy cell leukemia.Hairy Cell Leukemia (Kate

Updated on: October 15,2023

AstraZeneca to Discontinue Moxetumomab Pasudotox in US for Hairy Cell Leukemia

January 13, 2023Chris RyanMoxetumomab pasudotox-tdfk will be permanently discontinued in the United States market for the treatment of relapsed/refractory hairy cell leukemia.Hairy Cell Leukemia (Kate

Updated on:October 15,2023

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros

Updated on: March 12,2024

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros

Updated on:March 12,2024

Large study shows no strong link between baby powder, ovarian cancer

by Serena Gordon, Healthday Reporter(HealthDay)—There's been a longstanding debate—and a slew of lawsuits—over whether baby powder containing talc plays any role in the development of some cancers

Updated on: December 20,2023

Large study shows no strong link between baby powder, ovarian cancer

by Serena Gordon, Healthday Reporter(HealthDay)—There's been a longstanding debate—and a slew of lawsuits—over whether baby powder containing talc plays any role in the development of some cancers

Updated on:December 20,2023

Drug development in stem cell-derived liver organoid models

To ensure that new drugs are effective and have as little toxicity as possible, they first need to be tested in model systems before entering clinical trials. In this Q&A, Dr Takanori Takebe outli

Updated on: November 01,2023

Drug development in stem cell-derived liver organoid models

To ensure that new drugs are effective and have as little toxicity as possible, they first need to be tested in model systems before entering clinical trials. In this Q&A, Dr Takanori Takebe outli

Updated on:November 01,2023

Analysis of cancer treatment reveals need for standardized methods to measure waiting times

byeLifeCredit: Pixabay/CC0 Public DomainA review of associations between cancer waiting times and treatment outcomes highlights inconsistencies in reporting that make it hard to draw firm conclu

Updated on: December 20,2023

Analysis of cancer treatment reveals need for standardized methods to measure waiting times

byeLifeCredit: Pixabay/CC0 Public DomainA review of associations between cancer waiting times and treatment outcomes highlights inconsistencies in reporting that make it hard to draw firm conclu

Updated on:December 20,2023

ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

by Impact Journals LLCUpregulated genes and pathways enriched in glioblastoma cell lines treated with gartisertib combined with TMZ+RT. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28

Updated on: May 11,2024

ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

by Impact Journals LLCUpregulated genes and pathways enriched in glioblastoma cell lines treated with gartisertib combined with TMZ+RT. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28

Updated on:May 11,2024

Lung cancer cells covertly thrive in brain under guise of protection, study finds

by Krista Conger,Stanford University Medical CenterSmall cell lung cancer cells (green and blue) that metastasized to the brain in a laboratory mouse recruit brain cells called astrocytes (red)

Updated on: October 31,2023

Lung cancer cells covertly thrive in brain under guise of protection, study finds

by Krista Conger,Stanford University Medical CenterSmall cell lung cancer cells (green and blue) that metastasized to the brain in a laboratory mouse recruit brain cells called astrocytes (red)

Updated on:October 31,2023

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

Updated on: October 31,2023

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

Updated on:October 31,2023

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c

Updated on: October 11,2023

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c

Updated on:October 11,2023